TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
{{output}}
Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), remains challenging to manage, with a substantial proportion of patients not responding to conventional therapies or developing complications. The tumor necrosis ... ...